Keywords: Glutamine supplementation; Type 2 diabetes; Body composition; Insulin; GLP-1;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Type 2 diabetes mellitus; Quality of care; Chronic disease management; Effectiveness; Retrospective cohort study; ACE; angiotensin converting enzyme; ACHIL; Ambulatory Care Health Information Laboratory; ARB; angiotensin receptor blocker; ATC; anatomical
Keywords: AgRP; Aguoti gene-related peptide; AMPH; Amphetamine; BMI; Body mass index; CART; Cocaine- and amphetamine-related transcript; CATH; Cathinone; CCK; Cholecystokinin; CRH; Corticotropin-Releasing Hormone; DA; Dopamine; GLP-1; Glucagon-like peptide 1; LH; L
Keywords: GLP-1; GLP-2; Radiation-enteritis; Myeloperoxidase; Glutathione
Keywords: PYY; peptide YY; HIIE; high-intensity interval exercise; MIE; moderate-intensity exercise; GLP-1; glucagon-like peptide-1; VO2max; maximum oxygen uptake; PFC; prospective food consumption; AUC; area under the curve; Hypoxia; High altitude anorexia; High-i
Keywords: ANOVA; analysis of variance; BBB; blood-brain barrier; GDNF; glia-derived neurotrophic factor; GLP-1; glucagon-like peptide 1; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD; Parkinson's disease; TH; tyrosine
Keywords: NPs; nanoparticles; SC; subcutaneous/ly; STMP; sodium trimetaphosphate; MPs; microparticles; Eudragit L; Eudragit® L100-55; HPMC; hydroxypropylmethylcellulose; GLP-1; glucagon-like peptide-1; BSA; bovine serum albumin; DDW; bi-distilled water; Cryo-TEM;
Keywords: Insulin; Glucagon; GLP-1; GIP; Hyperglycemia;
Keywords: Erythropoietin; Innate repair receptor; β common receptor; Pyroglutamate helix B surface protein; ARA 290; ACTH; adrenocorticotropic hormone; AMPK; AMP-activated protein kinase; eNOS; endothelial nitric oxide·synthase; EPO; erythropoietin; EPOR; EPO rec
Keywords: Blood glucose; Coffee polyphenol; Flow-mediated dilatation; GLP-1; InsulinAUC, area under the curve; CGA, chlorogenic acid; CPE, coffee polyphenol extract; dROM, diacron-reactive oxygen metabolites; FMD, flow mediated dilation; GIP, glucose-dependent insu
Keywords: Aortic rings; Central (aortic) vasodilatation; GLP-1; Liraglutide;
Keywords: Aβ; amyloid β protein; AD; Alzheimer's disease; AGEs; advanced glycation end products; BSA; bovine serum albumin; CAT; catalase; DM; diabetes mellitus; Ex-4; exendin-4; GLP-1; glucagon-like peptide-1; GLP-1RA; glucagon-like peptide-1 receptor agonist;
Keywords: Enterohormones; Gastric bypass; GIP; GLP-1; Incretins; Superobesity;
Keywords: GLP-1; glycemic control; liraglutide; type 2 diabetes; weight loss;
Keywords: Leptin; Insulin; Glucagon; GLP-1; Diabetes; β cell; α cell; L-cellAUC, area under the curve; [Ca2+]i, intracellular free Ca2+ concentration; KATP, ATP-sensitive K+ channel; GTT, ITT, glucose and insulin tolerance test, respectively; IP, intraperitoneal; N
Keywords: ADP; adenosine diphosphate; ANT; adenine nucleotide transporter; ATP; adenine triphosphate; C1QBP; complement component 1Q subcomponent-binding protein; Ca2Â +; calcium; CK; creatine kinase; CsA; cyclosporine A; CYCLE; CYCLosporinE A in reperfused acute m
Keywords: DM; dry matter; GIP; glucose-dependent insulinotropic polypeptide; GIT; gastrointestinal tract; GLP-1; glucagon-like peptide-1; N; nitrogen; NDC; non-digestible carbohydrate; RDS; rapidly digestible starch; RS; resistant starch; RS1; resistant starch type
Keywords: alpha cells; diabetes; proglucagon; transdifferentiation; beta cells; GLP-1
Keywords: GluOC; uncarboxylated osteocalcin; GlaOC; γ-carboxylated osteocalcin; PKA; protein kinase A; ERK; extracellular signal-regulated kinase; PPAR; peroxisome proliferator-activated receptor; GLP-1; glucagon-like peptide-1; gWAT; gonadal white adipose tissue;
Keywords: GLP-1; glucagon-like peptide 1; 25OHD; 25-hydroxyvitamin D; RDA; recommended daily allowance; IGF-1; insulin-like growth factor 1; HDL; high density lipoprotein; HOMA-IR; homeostatic model assessment of insulin resistance; HbA1c; glycated hemoglobin; HFD;
Keywords: Glucagon-like peptide-1 receptor; Electrophysiology; Channelrhodopsin; Preproglucagon; GLP-1; PPGAP, area postrema; BNST, bed nucleus stria terminalis; DMH, dorsomedial nucleus of the hypothalamus; DMV, dorsal motor nucleus of the vagus; Ex-4, Exendin-4;
Keywords: GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; DPP-4; dipeptidyl peptidase-4; BMI; body mass index; CNS; central nervous system; EMA; European Medicines Agency; FDA; US Food and Drug Administration; (Pro3)GIP; proline-3
Keywords: ModEx; moderate-intensity aerobic continuous exercise; IntEx; high-intensity aerobic interval exercise; BMI; body mass index; NoEX; no exercise; VO2max; maximal oxygen uptake; GLP-1; glucagon-like peptide-1; GIP; glucose-dependent insulinotropic polypepti
Keywords: GLP-1; Liraglutide; Metformin; Gastrointestinal side effects;
Keywords: AA; arachidonic acid; ALP; alkaline phosphatase; ALX; G protein-coupled lipoxin A(4) receptor; AMP; adenosine monophosphate; BAT; brown adipose tissue; BMC; bone mineral content; BMD; bone mineral density; BMI; body mass index; CKD; chronic kidney disease
Keywords: ACC; acetyl-CoA carboxylase; AgRP; agouti-related peptide; AMPK; AMP-activated protein kinase; ARC; arcuate nucleus; BAT; brown adipose tissue; CART; cocaine- and amphetamine-regulated transcript; CCK; cholecystokinin; CNS; central nervous system; FGF; fi
Keywords: BBB; blood brain barrier; ARC; arcuate nucleus of hypothalamus; NPY; neuropeptide Y; AgRP; agouti-related peptide; POMC; pro-opiomelanocortin; αMSH; α-melanocyte stimulating hormone; LepRb; leptin receptor; JAK2; janus kinase 2; STAT3; signal transducer
Keywords: EIA; enzyme immunoassay; GLP-1; glucagon-like peptide-1; PEG; polyethylene glycol; NPH insulin; neutral protamine Hagedorn insulin; Type 2 diabetes; Insulin antibodies; Glargine; Detemir; Lispro; Aspart;
Keywords: Ghrelin; Blood glucose; Spinal cord; Intrathecal; Insulin; GLP-1
Keywords: Gustation; Eating behavior; CD36; Obesity; AEA; endocannabinoid anandamide; CCK; cholecystokinin; CVP; circumvallate papillae; DIO; diet-induced obesity; GLP-1; glucagon-like peptide-1; Glp1-r; GLP-1 receptor; GPCR; G protein-coupled receptors; LCFA; long
Keywords: Bariatric surgery; Psoriasis; GLP-1; Metabolic syndrome; Gastric bypass;
Keywords: Análogos del GLP-1; Célula beta; Diabetes mellitus tipo 2; DPP-4; GIP; GLP-1; Glucagón; Insulina; Obesidad; Vaciamiento gástrico; Beta cell; DPP-4; Gastric emptying; GIP; GLP-1; GLP-1 analogs; Glucagon; Insulin; Obesity; Type 2 diabetes mellitus;
Keywords: DV, surgical denervation of portal vein; SO, sham operation; GLP-1, glucagon-like peptide-1; OGTT, oral glucose tolerance test; HOMA-IR, homeostatic model assessment; AUC, area under the curvesPortal vein; GLP-1; Insulin sensitivity; Glucose tolerance
Keywords: DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; SD; Sprague-Dawley; NF-κB; nuclear factor-κB; GIP; gastric inhibitory polypeptide; ICAM-1; intercellular adhesion molecule-1; PAM; periodic acid-methenamine silver; cAMP; cyclic AMP; CRP;
Keywords: Glycated hemoglobin (HbA1c); Body weight; Postprandial plasma glucose (PPG); AE; adverse event; BMI; body mass index; DPP-4; dipeptidyl peptidase-4; FPG; fasting plasma glucose; GI; gastrointestinal; GLP-1; glucagon-like peptide-1; HbA1c; glycated hemoglo
Keywords: Whey protein consumption; Blood glucose; Insulin; GLP-1; Gastric emptying
Keywords: T2D; type 2 diabetes; M.F; milk fat; GLP-1; glucagon-like peptide-1; CCK; cholecystokinin; PYY; peptide tyrosine tyrosine; BMI; body mass index; ANOVA; analysis of variance; ISEC; Insulin SECretion; DPP-IV; dipeptidyl peptidase IV; Whole milk; Milk macron
Keywords: Intestine; Lipoprotein; Chylomicron; GLP-1; GLP-2; Resveratrol; Apo; apolipoprotein; CVD; cardiovascular diseases; DPP-4; dipeptidyl peptidase-4; FFA; free fatty acids; GIP; gastric inhibitory polypeptide; GLP-1; glucagon-like peptide-1; GLP-2; glucagon-l
Keywords: 5HT2C receptor; a subtype of 5-hydroxytryptamine receptor that binds the neurotransmitter serotonin; AgRP; agouti-related peptide; AITD; autoimmune thyroid disease; Akt1; a serine-threonine protein kinase; ARC; hypothalamic arcuate nucleus; BMI; Body-Ma
Keywords: blood pressure; DPP-4 inhibitors; GLP-1; GLP-1R agonists; hypertension; incretins; type 2 diabetespression artérielle; inhibiteurs de la DPP-4; GLP-1; agonistes du GLP-1R; hypertension; incrétines; diabète de type 2
Keywords: Exenatide; Exendin 4; GLP-1; Parkinson's disease; Clinical trial design;
Keywords: ATPase; adenosine triphosphatase; eGFR; estimated glomerular filtration rate; EGP; endogenous glucose production; FPG; fasting plasma glucose; FRG; familial renal glucosuria; GFR; glomerular filtration rate; GGM; glucose-galactose malabsorption; GLP-1; gl
Keywords: AGE; advanced glycation end product; aBMD; areal bone mineral density; BMD; bone mineral density; BMI; body mass index; DPP-4; dipeptidyl peptidase-4; DXA; dual-energy X-ray absorptiometry; eBMD; estimated bone mineral density; GLP-1; glucagon-like peptid
Keywords: Non-alcoholic steatohepatitis (NASH); Sitagliptin; MCD diet; GLP-1; DPP-4 inhibitor;
Keywords: Oxyntomodulin; Glucagon; GLP-1; Glucose metabolism; Body weight
Keywords: ACE-I; angiotensin-converting enzyme inhibitor; ARB; angiotension receptor blocker; BMI; body mass index; Cr; creatinine; CVD; cardiovascular disease; DPP-4; dipeptidyl peptidase 4; GAD-65; glutamic acid decarboxylase; GLP-1; glucagon-like peptide 1; GFR;
Keywords: ABA; abscisic acid; PA; phaseic acid; DPA; dihydrophaseic acid; 7-OH-ABA; 7-hydroxy-abscisic acid; ABA-GE; abscisic acid glucose ester; trans-ABA; trans abscisic acid; Neo-PA; neo-phaseic acid; HbA1c; higher glycated haemoglobin 1c; CVD; cardiovascular di
Keywords: DAPI; 4â²,6-diamidino-2-phenylindole; EIA; enzyme-linked immunoassay; GLP-1; glucagon-like peptide-1; GluOC; uncarboxylated osteocalcin; IPGTT; intraperitoneal glucose tolerance test; OGTT; oral glucose tolerance test; PCNA; proliferating cell nuclear an
Keywords: Type 2 diabetes; Cardiovascular; Glucose; GLP-1; DPP-4; SGLT-2
Keywords: AD; Alzheimer's disease; EDTA; ethylenediaminetetraacetic acid; Ex-4; exendin-4; GLP-1; glucagon-like peptide 1; GLP-1R; GLP-1 receptor; GSH; glutathione; MCAO; middle cerebral artery occlusion; MDA; malondialdehyde; NGF; nerve growth factor; PFA; paraf